Phytochemical and Biological Review of Aegle Marmelos Linn

Abstract

India has one of the most expanded plant-origin medical traditions in the world. Researchers have evaluated molecules obtained from plants to treat a variety of ailments. Literature review shows that fundamental parts of the plant are used to treat different diseases. The related data is retrieved from Google scholar, PubMed, Science Direct and Scopus. The keywords include Bael, A. marmelos, Vilvam, and Marmelosin. Extensive studies show that A. marmelos has antidiarrhoeal, antimicrobial, antiviral, anticancer, chemopreventive, antipyretic, ulcer healing, antigenotoxic, diuretic, antifertility, and anti-inflammatory properties. In this work, an updated literature review is presented to clarify the current state of research on A. marmelos elucidating its constituents and their most relevant biological activities.

Plain Language Summary

India has one of the most expanded plant-origin medical traditions in the world. A. marmelos Linn, also familiar as bael, belongs to Rutaceae and is widely grown worldwide. A. marmelos is a fruit with various medicinal advantages. We searched various databases, studied elaborately, and understood the importance of this fruit. Thus, its constituents can help mitigate various diseases.

Graphical abstract

Keywords:

• Aegle marmelos
• Marmelosin
• phytochemistry
• Rutaceae
• Vilvam

Author contributions

Literature research and writing have been done by S Monika and M Thirumal. Actualization has been done by PR Kumar. English vocabulary as well as phrase structure revision of the whole document have been done by S Monika. M Thirumal was the supervisor of all work.

Acknowledgments

The authors express sincere gratitude to all the supervisors and professors of SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur (Tamil Nadu, India), who extended their contribution and support in this work.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.